Sixty years from THC: landscape and perspectives on the pharmacology of cannabinoids
For instance, we are particularly interested in:
clinical studies/trials and reviews (scope, systematic and meta-analysis) investigating eCBS-acting compounds as well as drugs acting on CBR-related targets.
original studies and reviews (scope, systematic and meta-analysis) describing the role of eCBS in animal models, and drug screening and development methods.
the sociological aspects and public health impact of the recreational/therapeutic use of the plant or derivatives on policy, legislation and industry following legalization/decriminalization.
Guest editors:
Fabricio Moreira - Belo Horizonte, Federal University of Minas Gerais, Brazil
Uwe Grether - F Hoffmann-La Roche Ltd, Basel, Switzerland.
Luigia Cristino - National Research Council, Roma, Italy.
Manuscript submission information:
Submission Deadline: 30th November 2024
The journal’s submission platform (https://www2.cloud.editorialmanager.com/jphs/default2.aspx) is now available for receiving submissions to this Special Issue. Please refer to the Guide for Authors to prepare your manuscript and select the article type "VSI:Pharmacology of Cannabinoids" when submitting your manuscript online. Both the Guide for Authors and the submission portal could be found on the Journal Homepage here: https://www.sciencedirect.com/journal/journal-of-pharmacological-sciences
Keywords:
Cannabis, cannabinoids, pharmacology, THC
Journal of Pharmacological Sciences的CAR指数
2023年3月份科睿唯安官方一次性踢除35本SCI期刊，多数涉及学术诚信问题，让我们意识到学术期刊的“被踢”指数，也很重要。目前，对于期刊的“被踢”指数，这里介绍一下：CAR指数（关于CAR的详细介绍，请关注：www.jcarindex.com），这是一种评价期刊学术诚信风险的指数，指数越高代表可能的风险越大。从数据看，Journal of Pharmacological Sciences不管是2022年度，还是2023年度的CAR指数，都是比较低的。当然，CAR指数仅供参考，期刊风险情况，需以科睿唯安或中科院预警等官方为准！
让推送更美好~
